Hematopoietic stem cell heterogeneity is linked to the initiation and therapeutic response of myeloproliferative neoplasms. Tong J, Sun T, Ma S, Zhao Y, et al. Cell Stem Cell 2021;28:780.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tong J, Sun T, Ma S, Zhao Y, et al. Hematopoietic stem cell heterogeneity is linked to the initiation and therapeutic response of myeloproliferative neoplasms. Cell Stem Cell 2021;28:780.
PMID: 33798424